EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Validez en la predicción de riesgo de la escala SCORE en una población mediterránea con hipertensión arterial

Francisco J Sanz-Garcia, José A Quesada, Concepción Carratala-Munuera, Domingo Orozco-Beltrán, Vicente F Gil-Guillén, María J Prieto-Castello, Dolores Marhuenda-Amorós, Rafael M Micó Pérez, Felipe Navarro Cremades, Alberto Cordero, Vicente Bertomeu-Gonzalez, Vicente Arrarte

Medicina Clínica · 2024-02 · 162 (3) · 112-117

DOI: 10.1016/j.medcli.2023.09.009 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Medicina Clínica, 2024-02. Verfasst von Francisco J Sanz-Garcia und 11 weiteren Autor:innen. Beteiligte Einrichtung: Departamento de Medicina Clínica, Universidad Miguel Hernández, Campus de San Juan, Alicante, España; Centro de Salud Muro de Alcoy, Muro d'Alcoi, Al…. Hauptthemen laut MEDLINE: Hypertension, Cardiovascular Diseases. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION AND OBJECTIVES: Hypertension is the most prevalent risk factor globally. Calculation of cardiovascular risk in hypertensive patients before initiation of treatment is recommended. This study aimed to assess the predictive value and clinical utility of the SCORE scale in preventing cardiovascular events and all-cause mortality in patients with hypertension. METHODS: Patients with hypertension from the ESCARVAL-RISK cohort were included. Cardiovascular risk was calculated using the SCORE scale. All deaths and cardiovascular events were recorded during a 5-year follow-up period. Sensitivity, specificity and predictive values were calculated for different cut-off points and the effect of different risk factors on the diagnostic accuracy of SCORE charts were assessed. RESULTS: In a final cohort of 9834 patients, there were 555 cardiovascular events and 69 deaths. The recommended risk value for initiating drug treatment (5%) had a specificity of 92% for death and 91% for cardiovascular events, and a sensitivity of 20% for death and 22% for cardiovascular events. In addition, the scale classified 80.4% of patients who experienced a cardiovascular event and 78.3% of those who died as low risk. Age, body mass index, retinopathy and anticoagulant therapy were associated with reduced predictive ability of the SCORE scale, while being female was associated with better risk prediction. CONCLUSIONS: The predictive ability of the SCORE scale for cardiovascular disease and total mortality in patients with hypertension is limited.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HypertensionCardiovascular DiseasesHumansFemaleMaleRisk FactorsBody Mass IndexHeart Disease Risk Factors

Stichwörter der Autor:innen

Arterial hypertensionCardiovascular diseaseCardiovascular riskEnfermedad cardiovascularEscalas de riesgoHipertensión arterialRiesgo cardiovascularRisk scales

Autor:innen und Institutionen

  • Departamento de Medicina Clínica, Universidad Miguel Hernández, Campus de San Juan, Alicante, España; Centro de Salud Muro de Alcoy, Muro d'Alcoi, Alicante, España.
  • Departamento de Medicina Clínica, Universidad Miguel Hernández, Campus de San Juan, Alicante, España.
  • Cátedra de Medicina de Familia, Departamento de Medicina Clínica, Universidad Miguel Hernández, Campus de San Juan, Alicante, España.
  • Departamento de Patología y Cirugía, Universidad Miguel Hernández, Campus de San Juan, Alicante, España.
  • Cátedra de cronicidad SEMERGEN-UMH, Departamento de Medicina Clínica, Universidad Miguel Hernández, Campus de San Juan, Alicante, España.
  • Departamento de Medicina Clínica, Universidad Miguel Hernández, Campus de San Juan, Alicante, España; Cátedra de cronicidad SEMERGEN-UMH, Departamento de Medicina Clínica, Universidad Miguel Hernández, Campus de San Jua…

Zitieren

APA

Sanz-Garcia, F. J., Quesada, J. A., Carratala-Munuera, C., Orozco-Beltrán, D., Gil-Guillén, V. F., Prieto-Castello, M. J., Marhuenda-Amorós, D., Micó Pérez, R. M., Navarro Cremades, F., Cordero, A., Bertomeu-Gonzalez, V., & Arrarte, V. (2024). Validez en la predicción de riesgo de la escala SCORE en una población mediterránea con hipertensión arterial. Medicina Clínica, 162(3), 112-117. https://doi.org/10.1016/j.medcli.2023.09.009

Vancouver

Sanz-Garcia FJ, Quesada JA, Carratala-Munuera C, Orozco-Beltrán D, Gil-Guillén VF, Prieto-Castello MJ, et al. Validez en la predicción de riesgo de la escala SCORE en una población mediterránea con hipertensión arterial. Medicina Clínica. 2024;162(3):112-117. doi:10.1016/j.medcli.2023.09.009

BibTeX
@article{SanzGarcia2024,
  author = {Sanz-Garcia, Francisco J and Quesada, José A and Carratala-Munuera, Concepción and Orozco-Beltrán, Domingo and Gil-Guillén, Vicente F and Prieto-Castello, María J and Marhuenda-Amorós, Dolores and Micó Pérez, Rafael M and Navarro Cremades, Felipe and Cordero, Alberto and Bertomeu-Gonzalez, Vicente and Arrarte, Vicente},
  title = {Validez en la predicción de riesgo de la escala SCORE en una población mediterránea con hipertensión arterial},
  journal = {Medicina Clínica},
  year = {2024},
  volume = {162},
  number = {3},
  pages = {112--117},
  doi = {10.1016/j.medcli.2023.09.009}
}
Kostenlos starten →